Surgery Doctors in Fairfield, CT Accepting Medicare

11 Surgery doctors found. Showing 1 - 11

Dr. Paul Dean Demartini, M.D. Surgery - Vascular Surgery Medicare: Medicare Enrolled Practice Location: 501 Kings Hwy E, Suite 112, Fairfield, CT 06825 Phone: 203-382-1900    Fax: 203-382-0019

Mark Charles Steckel, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 140 Sherman Street, Fairfield, CT 06824 Phone: 203-256-1320    Fax: 203-256-8736

Dr. Andrew Raymond Baxter, Surgery - Vascular Surgery Medicare: Accepting Medicare Assignments Practice Location: 75 Kings Highway Cutoff, Fairfield, CT 06824 Phone: 203-266-1735

Dr. Alph Jo Emmanuel, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 140 Sherman St Fl 2, Fairfield, CT 06824 Phone: 860-840-1819

Dr. Leslie Mark Kutcher, M.D. Surgery - Vascular Surgery Medicare: Not Enrolled in Medicare Practice Location: 52 Beach Rd, Suite 207, Fairfield, CT 06824 Phone: 203-255-2003    Fax: 203-319-7583

Dr. Seth Barak Blattman, M.D. Surgery - Vascular Surgery Medicare: Accepting Medicare Assignments Practice Location: 501 Kings Hwy E, Suite 112, Fairfield, CT 06825 Phone: 203-382-1900    Fax: 203-382-0019

Dr. Roselle Eisma Crombie, M.D./M.P.H Surgery Medicare: Accepting Medicare Assignments Practice Location: 111 Beach Rd, Fairfield, CT 06824 Phone: 203-254-8244

Dr. Saber Ghiassi, MD, MPH Surgery Medicare: Accepting Medicare Assignments Practice Location: 2000 Post Rd, Suite 101, Fairfield, CT 06824 Phone: 203-418-9520    Fax: 203-418-9530

Jennifer S. Schwartz, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 2000 Post Rd Ste 101, Fairfield, CT 06824 Phone: 203-418-9520

Dr. James V Lettera, M.D. Surgery - Vascular Surgery Medicare: Accepting Medicare Assignments Practice Location: 501 Kings Hwy E, Suite 112, Fairfield, CT 06825 Phone: 203-382-1900    Fax: 203-382-0019

Nikhilesh Royopet Sekhar, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 140 Sherman St, Fairfield, CT 06824 Phone: 516-616-5500    Fax: 888-502-6582

News Archive

New strategy may combat age-associated infertility and birth defects

A strategy that has been shown to reduce age-related health problems in several animal studies may also combat a major cause of age-associated infertility and birth defects.

Merck announces FDA Advisory Committee approval of GARDASIL for anal cancer and AIN treatment

Merck announced today that the U.S. Food and Drug Administration's (FDA) Vaccines and Related Biological Products Advisory Committee has advised that the data presented support an indication for GARDASIL® [Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant] for the prevention of anal cancer and anal intraepithelial neoplasia (AIN) in both males and females 9 through 26 years of age.

New anti-cancer medications may help in managing cancerous conditions

Bold new strategies in the battle against cancer may turn forms of the disease that presently are incurable into manageable conditions that can be controlled for long periods of time, according to an article in the current issue of Chemical & Engineering News, ACS' weekly newsmagazine.

USP announces revision schedule for Model Guidelines Version 5.0

As the Medicare Model Guidelines-a listing of therapeutic categories and pharmacologic classes that Medicare Part D plans can utilize when developing their formularies-undergo revision for the first time in three years, the U.S. Pharmacopeial Convention (USP) is announcing its revision schedule and the expanded opportunities for public input as it develops Version 5.0.

ISTA commences bepotastine besilate nasal spray Phase 2 study in seasonal allergic rhinitis

ISTA Pharmaceuticals, Inc., today announced it has initiated a Phase 2 clinical study of bepotastine besilate nasal spray for the treatment of symptoms associated with seasonal allergic rhinitis, the inflammation of the nasal passages caused by allergies. The randomized, placebo-controlled, parallel-group environmental study will evaluate the safety and efficacy of bepotastine besilate, dosed twice daily, in patients presenting with allergic rhinitis caused by one of the most potent seasonal allergy triggers, Mountain Cedar pollen.

Read more Medical News

› Verified 7 days ago